Representative before the EPO

Company dna abel and imray
no operation time available
1026.5
3 offices
active in Legal Services

We have observed 34 EP applications Paul Andrew Brady has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11743315

COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/20
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP11785050

PEG OR PEG BLOCK COPOLYMERS FOR TREATING COLORECTAL CANCER

IPC classification:
A61K 31/765, A61P 35/00
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP11785049

FORMULATIONS COMPRISING POLYETHYLENE GLYCOL

IPC classification:
A61K 9/20, A61K 31/765, A61P 1/10
Agent:
Paul Andrew Brady, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP12710777

COLONOSCOPY - PREPARATION

IPC classification:
A61K 9/00, A61K 31/375, A61K 47/10, A61P 1/10
Agent:
Paul Andrew Brady, Abel & Imray
Status:
PATENT GRANTED
EP12770994

PITAVASTATIN-CONTAINING PREPARATION AND METHOD FOR PRODUCING SAME

IPC classification:
A61K 31/47, A61K 47/02, A61P 3/06
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP11745440

LONG-ACTING INSULIN ANALOGUE PREPARATIONS IN SOLUBLE AND CRYSTALLINE FORMS

IPC classification:
A61K 9/00, A61K 38/28
Applicant:
Case Western Reserve University
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP11738455

NOVEL COMPOUNDS AND THEIR EFFECTS ON FEEDING BEHAVIOUR

IPC classification:
C07K 14/575, C07K 14/605, C07K 19/00
Applicant:
Imperial Innovations Limited
Agent:
Multiple attorneys, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP12745463

NOVEL ESTROGEN RECEPTOR LIGANDS

IPC classification:
C07D 213/58, C07D 215/12, C07D 217/14, C07D 231/12, C07D 233/64, C07D 235/16, C07D 261/08, C07D 277/30, C07D 277/34, C07D 307/54, C07D 307/68, C07D 307/87, C07D 317/60, C07D 333/20, C07D 409/10
Agent:
Toby Alexander Thompson, Kilburn & Strode LLP
Agent:
Multiple attorneys, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP12777417

COMPOSITIONS AND METHODS

IPC classification:
A61K 31/08, A61K 31/337, A61K 31/513, A61K 31/519, A61K 31/765, A61K 39/00, A61K 45/06, A61P 35/00
Applicant:
NorthShore University HealthSystem
Agent:
Paul Andrew Brady, Abel & Imray
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12821100

PROCESS FOR THE PRODUCTION OF POLY (ETHYLENE 2,5- FURANDICARBOXYLATE) FROM 2,5-FURANDICARBOXYLIC ACID AND USE THEREOF, POLYESTER COMPOUND AND BLENDS THEREOF

IPC classification:
C08G 63/16, C08G 63/85
Applicant:
Natura Cosmeticos S.A.
Agent:
Paul Andrew Brady, Abel & Imray
Status:
PATENT GRANTED
EP12788729

AN ADULT STEM CELL LINE INTRODUCED WITH HEPATOCYTE GROWTH FACTOR GENE AND NEUROGENIC TRANSCRIPTION FACTOR GENE WITH BASIC HELIX-LOOP-HELIX MOTIF AND USES THEREOF

IPC classification:
A61K 35/12, A61K 35/28, A61P 25/00, C12N 5/074, C12N 5/10, C12N 15/861
Applicant:
Ajou University Industry-Academic Cooperation Foundation
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP13721004

QUINAZOLINE COMPOUNDS AND THEIR USE IN THERAPY

IPC classification:
A61K 31/517, A61P 25/28, A61P 31/18, A61P 35/00, C07D 239/95, C07D 401/12, C07D 401/14, C07D 405/14, C07D 491/056
Applicant:
Emory University
Applicant:
Imperial Innovations Limited
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP14194902

Method of determining the susceptibility to statin-induced myopathy

IPC classification:
C12Q 1/68
Applicant:
Oxford University Innovation Ltd
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP14194194

Improvements in and relating to compositions

IPC classification:
A61K 9/00, A61K 9/08
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP12702615

IMPROVEMENTS IN AND RELATING TO COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/08
Agent:
Paul Andrew Brady, Abel & Imray
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13766633

PEPTIDE ANALOGUES OF GLUCAGON AND GLP1

IPC classification:
C07K 14/605
Applicant:
Imperial Innovations Limited
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP13762101

COMPOSITIONS COMPRISING PEG AND ASCORBATE

IPC classification:
A61K 9/00, A61K 31/375, A61K 47/10, A61P 1/10
Agent:
Paul Andrew Brady, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP13861465

PROTEIN EXPRESSION ENHANCING POLYPEPTIDES

IPC classification:
C12N 5/07, C12N 5/16, C12P 21/04, C12P 21/06
Agent:
Multiple attorneys, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP12890281

COMPOSITION SENSITIVE TO RADIATION IN ELECTROMAGNETIC SPECTRUM RANGES FOR PRINTING PURPOSES, PRINTING PLATE COMPRISING SAID COMPOSITION, USE OF SAID COMPOSITION AND IMAGE DEVELOPMENT PROCESS

IPC classification:
G03C 1/73, G03F 7/028
Applicant:
IBF (IBF Indústria Brasileira de Filmes SA)
Agent:
Paul Andrew Brady, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP14786040

NOVEL 3-(4-(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE, METHOD OF PREPARING SAME AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC DISEASE INCLUDING SAME AS EFFECTIVE INGREDIENT

IPC classification:
A61K 31/357, A61P 3/10, C07D 317/72
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION REQUESTED
EP14787683

BENZIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING BENZIDINE DERIVATIVE FOR TREATING LIVER DISEASE CAUSED BY HEPATITIS C VIRUS

IPC classification:
A61K 31/4025, A61P 31/12, C07D 403/12
Applicant:
Postech Academy-Industry Foundation
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION REQUESTED
EP14804005

SUPER-COMPLEX FORMED BY CROSS-BINDING BETWEEN COMPLEXES OF REPEATING CHAIN AND MONOMER, AND USE THEREOF

IPC classification:
C07K 1/00, C12N 15/09, G01N 33/53, G01N 33/68
Agent:
Paul Andrew Brady, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP14823233

SALT PRODUCTS COATED WITH NATURAL AMINO ACIDS EXTRACTS FOR SODIUM INTAKE REDUCTION

IPC classification:
A23L 27/40
Agent:
Multiple attorneys, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP14844012

NUCLEOTIDE AND NUCLEOSIDE COMPOSITIONS AND USES RELATED THERETO

IPC classification:
A61K 31/706, A61K 31/7068, A61P 31/14, C07H 19/06
Applicant:
Emory University
Agent:
Paul Andrew Brady, Abel & Imray
Status:
GRANT OF PATENT INTENDED
EP11385201

Lever mechanism for adjustable pliers

IPC classification:
B25B 7/10
Agent:
Paul Andrew Brady, Abel & Imray
Agent:
James L.C. Sanderson, Sanderson & Co.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13896725

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES CONTAINING FLUOXETINE AND VITAMIN C AS ACTIVE INGREDIENTS

IPC classification:
A61K 31/135, A61K 31/138, A61K 31/375, A61P 25/00
Agent:
Multiple attorneys, Abel & Imray
Status:
EXAMINATION REQUESTED
EP10859285

CDK-INHIBITING PYRROLOPYRIMIDINONE CARBOXAMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING LIVER CELL CANCER

IPC classification:
A61K 31/7068, A61P 35/00, C07H 19/14
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Paul Andrew Brady, Abel & Imray
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14864546

NERVE-CELL-REGENERATING OR NERVE-CELL GROWTH-PROMOTING PHARMACEUTICAL COMPOSITION CONTAINING VAX PROTEIN AS ACTIVE INGREDIENT

IPC classification:
A61K 38/16, A61K 48/00, A61P 25/00
Applicant:
Korea Advanced Institute of Science and Technology
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION REQUESTED
EP14861999

POLYPORUS SQUAMOSUS-DERIVED RECOMBINANT LECTIN SPECIFIC FOR SIALIC ACID LINKAGE

IPC classification:
C12N 1/21, C12N 15/31, C12N 15/63, C12N 15/81
Applicant:
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Agent:
Multiple attorneys, Abel & Imray
Status:
EXAMINATION IN PROGRESS
EP14824845

PRODRUGS OF UROLITIHNS AND USES THEREOF

IPC classification:
A61K 31/366, A61P 3/00, C07D 311/80
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION REQUESTED
EP14877308

FABS-IN-TANDEM IMMUNOGLOBULIN AND USES THEREOF

IPC classification:
C07K 16/00
Agent:
Paul Andrew Brady, Abel & Imray
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP15743007

NOVEL 2-PHENYLBENZOFURAN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASE COMPRISING SAME AS ACTIVE INGREDIENT

IPC classification:
A61K 31/085, A61K 31/09, A61K 31/343, A61P 29/00, C07C 43/23, C07D 307/79, C07D 307/80, C07D 307/81
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION REQUESTED
EP15709665

METHOD OF CLEANSING THE COLON

IPC classification:
A61K 9/00, A61K 31/375, A61K 31/765, A61K 33/04, A61K 33/14, A61K 47/10, A61P 1/10
Agent:
Paul Andrew Brady, Abel & Imray
Status:
EXAMINATION REQUESTED
EP16173824

COLONOSCOPY - PREPARATION

IPC classification:
A61K 9/00, A61K 31/375, A61K 47/10, A61P 1/10
Agent:
Paul Andrew Brady, Abel & Imray
Status:
Request for examination was made

Please Sign in to use this feature